Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis

Kidney International

Volumn 56, Issue 6, 1999, Pages 2147-2159

  Shihab, Fuad S ^a,b   Andoh, Takeshi F ^a,b   Tanner, Amie M ^a,b   Yi, Hong ^a,b   Bennett, William M ^a,b  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Death genes; Fibrosis; Immunosuppression; Nephrotoxicity; Programmed cell death

Indexed keywords

CASPASE 3; CYCLOSPORIN; FAS ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FIBROSIS; LYMPHOCYTE ACTIVATION; MALE; NEPHROTOXICITY; NICK END LABELING; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATOR GENE; WESTERN BLOTTING;

EID: 0033405266     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00794.x     Document Type: Article

References (60)

1. 1. Nagata S: Apoptosis by death factor. Cell 88:355-365, 1997
2. 2. Schwartzman RA, Cidlowski JA: Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocr Rev 14:133-151, 1993
3. 3. Ellis RE, Yuan JY, Horvitz HR: Mechanisms and functions of cell death. Annu Rev Cell Biol 7:663-698, 1991
4. 4. Savill J: Apoptosis and the kidney. J Am Soc Nephrol 5:12-21, 1994
5. 5. Savill J, Mooney A, Hughes J: Apoptosis and renal scarring. Kidney Int 49:S14-S17, 1996
6. 6. Corcoran GB, Fix L, Jones DP, Molsen MT, Nicotera P, Oberhammer FA: Apoptosis: Molecular control point in toxicity. Toxicol Appl Pharmacol 128:169-181, 1994
7. 7. Dive C, Hickman JA: Drug-target interactions: Only the first step in the commitment to a programmed cell death? Br J Cancer 64:192-196, 1991
8. 8. Lennon SV, Martin SJ, Cotte TG: Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif 24:203-214, 1991
9. 9. Harris DJ: Cell death in the diseased glomerulus. Histopathology 12:679-683, 1988
10. 10. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J: Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 94:2105-2116, 1994
11. 11. Shimizu A, Kitamura H, Masuda Y, Ischizaki M, Sugisaki Y, Yamanaka N: Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int 47:114-121, 1995
12. 12. Tang MJ, Cheng YR, Lin HH: Role of apoptosis in growth and differentiation of proximal tubule cells in primary cultures. Biochem Biophys Res Commun 218:658-664, 1996
13. 13. Koseki C, Herzlinger D, Al-Awqati Q: Apoptosis in metanephric development. J Cell Biol 119:1327-1333, 1992
14. 14. Lieberthal W, Levine JS: Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am J Physiol 271:F477-F488, 1996
15. 15. Lieberthal W, Triaca V, Levine J: Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: Apoptosis vs. necrosis. Am J Physiol 270:F700-F708, 1996
16. 16. Gobé GC, Axelsen RA, Searle JW: Cellular events in experimental unilateral ischemic renal atrophy and in regeneration after contralateral nephrectomy. Lab Invest 63:770-779, 1990
17. 17. Schumer M, Colombel MC, Sawczuk IS, Gobe G, Connor J, O'Toole KM, Olson CA, Wise GJ, Buttyan R: Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 140:831-838, 1992
18. 18. Gobé GC, Axelsen RA: Genesis of renal tubular atrophy in experimental hydronephrosis in the rat: Role of apoptosis. Lab Invest 56:273-281, 1987
19. 19. Woo D: Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med 333:18-25, 1995
20. 20. Kahan BD: Cyclosporine. N Engl J Med 321:1725-1738, 1989
21. 21. Bennett WM, Demattos A, Meyer MM, Andoh T, Barry J: Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy. Kidney Int 50:1089-1100, 1996
22. 22. Shihab FS: Cyclosporine nephropathy: Pathophysiology and clinical impact. Semin Nephrol 16:536-547, 1996
23. 23. Myers BD, Ross JC, Newton LD, Luetscher JA, Perloth MG: Cyclosporine-associated chronic nephropathy. N Engl J Med 311:600-705, 1984
24. 24. Andoh TF, Burdmann EA, Bennett WM: Nephrotoxicity of immunosuppressive drugs: Experimental and clinical observations. Semin Nephrol 17:34-45, 1997
25. 25. Shihab FS, Andoh TF, Tanner AM, Noble NA, Franceschini N, Bennett WM: Role of transforming growth factor-β1 in experimental chronic cyclosporine nephropathy. Kidney Int 49:1141-1151, 1996
26. 26. Shihab FS, Andoh TF, Tanner AM, Bennett WM: Salt-depletion enhances TGF-β1 and matrix proteins expression in rat chronic cyclosporine nephropathy. Am J Kidney Dis 30:71-81, 1997
27. 27. Shihab FS, Bennett WM, Tanner AM, Andoh TF: Angiotensin II blockade decreases TGF-β1 and matrix proteins in cyclosporine nephropathy. Kidney Int 52:660-673, 1997
28. 28. Thomas SE, Andoh TF, Pichler RH, Shankland SJ, Couser WG, Bennett WM, Johnson RJ: Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int 53:897-908, 1998
29. 29. Evan G, Littlewood T: A matter of life and cell death. Science 281:1317-1322, 1998
30. 30. Zhan Q, Carrier F, Fornace AJ: Induction of cellular p53 activity by DNA damaging agents and growth arrest. Mol Cell Biol 13:4242-4250, 1993
31. 31. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 is required for radiation induced apoptosis in mouse thymocytes. Nature 362:847-849, 1993
32. 32. Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299, 1995
33. 33. Adams JM, Cory S: The Bcl-2 protein family: Arbiters of cell survival. Science 281:1322-1326, 1998
34. 34. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog Bax that accelerates programmed cell death. Cell 74:609-619, 1993
35. 35. Zhan Q, Fan S, Bae I, Guellouf C, Liebermann DA, O'Connor PM, Fornace AJ: Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene 9:3743-3751, 1994
36. 36. Nagata S, Golstein P: The Fas death factor. Science 267:1449-1456, 1995
37. 37. Thornberry N, Lazebnik Y: Caspases: Enemies within. Science 281:1312-1316, 1998
38. 38. Ito H, Kasaki N, Shomori K, Osaki M, Adachi H: Apoptosis in the human allografted kidney: Analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling. Transplantation 60:794-798, 1995
39. 39. Shihab FS, Yamamoto T, Nast CC, Cohen AH, Gold LI, Noble NA, Border WA: Transforming growth factor-β and extracellular proteins expression in acute and chronic rejection of human renal allografts. J Am Soc Nephrol 6:286-294, 1995
40. 40. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z: Apoptosis in glomerular sclerosis. Kidney Int 49:103-111, 1996
41. 41. Chevalier RL: Growth factors and apoptosis in neonatal ureteral obstruction. J Am Soc Nephrol 7:1098-1105, 1996
42. 42. Truong LD, Petrusevka G, Yang G, Gurpinar T, Shappell S, Lechago J, Rouse D, Suki W: Cell apoptosis and proliferation in experimental chronic obstructive uropathy. Kidney Int 50:200-207, 1996
43. 43. Kennedy WA, Stenberg A, Lackgren G, Hensle TW, Sawczuk IS: Renal tubular apoptosis after partial ureteral obstruction. J Urol 152:658-664, 1994
44. 44. Ortiz A, Lorz C, Gonzalez-Cuadrado S, Garcia del Moral R, O'Valle F, Egido J: Cytokines and Fas regulate apoptosis in murine renal interstitial fibroblasts. J Am Soc Nephrol 8:1845-1854, 1997
45. 45. Morrissey JJ, Ishidoya S, McCracken R, Klahr S: The effect of ACE inhibitors on the expression of matrix genes and the role of p53 and p21 (WAF1) in experimental renal fibrosis. Kidney Int 54(Suppl):S83-S87, 1996
46. 46. Sandau K, Pfeilschifter J, Brüne B: Nitric oxide and superoxide induced p53 and Bax accumulation during mesangial cell apoptosis. Kidney Int 52:378-386, 1997
47. 47. Ortiz A, Ziyadeh FN, Neilson EG: Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. J Invest Med 45:50-56, 1997
48. 48. Hockenbery DM, Oltavi ZN, Yin X-M, Milliman CL, Korsmeyer SL: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251, 1993
49. 49. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:384-387, 1992
50. 50. Healy E, Dempsey M, Lally C, Ryan MP: Apoptosis and necrosis: Mechanisms of cell death induced by cyclosporine A in renal proximal tubular cell line. Kidney Int 54:1955-1966, 1998
51. 51. Nogae S, Miyazaki M, Kobayashi N, Saito T, Abe K, Saito H, Nakane PK, Nakanishi Y, Koji T: Induction of apoptosis in ischemia-reperfusion model of mouse kidney: Possible involvement of Fas. J Am Soc Nephrol 9:620-631, 1998
52. 52. Yang CW, Faulkner GR, Christianson TA, Bagby GC, Stein LM, Bagby SP, Lindsley JN, Bennett WM, Andoh TF: Apoptotic cell death in chronic cyclosporine nephrotoxicity: Involvement of Fas and Fas-ligand. Transplantation (in press)
53. 53. Nakajima H, Oka T: The inhibition of T-cell-receptor-induced Fas ligand upregulation by cyclosporine and FK 506. Transplant Proc 28:1052-1055, 1996
54. 54. Brunner T, Yoo NJ, Laface D, Ware CF, Green DR: Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporine A and FK506. Int Immunol 8:1017-1026, 1996
55. 55. Wilson KP, Black JA, Thomson JA, Kim EE, Griffith JP, Navia MA, Murcko MA, Chambers SP, Aldape RA, Raybuck SA, Livingston DJ: Structure and mechanism of interleukin-1β converting enzyme. Nature 370:270-275, 1994
56. 56. Ortiz A, Lorz C, Catalán M, Ortiz A, Coca S, Egido J: Cyclosporine A induces apoptosis in murine tubular epithelial cells: Role of caspases. Kidney Int 68(Suppl):S25-S29, 1998
57. 57. Cigola E, Kajstura J, Li B, Meggs LG, Anversa P: Angiotensin II activates programmed cell death in vitro. Exp Cell Res 231:363-371, 1997
58. 58. Oberhammer FA, Pavelka M, Sharma S, Tiefenbacher R, Purchio AF, Bursch W, Schulte-Hermann R: Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc Natl Acad Sci USA 89:5408-5412, 1992
59. 59. Leri A, Claudio PP, Li Q, Wang X, Reiss K, Wang S, Malhotra A: Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest 101:1326-1342, 1998
60. 2+ elevation and cyclosporine A synergistically induce TGF-β1-mediated apoptosis in lymphocytes. J Immunol 158:2527-2534, 1997